Oculomucocutaneous syndrome
| Oculomucocutaneous syndrome | |
|---|---|
| Synonyms | Stevens-Johnson syndrome, Lyell's syndrome |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Conjunctivitis, keratitis, skin rash, oral ulcers |
| Complications | Blindness, scarring, infection |
| Onset | Sudden |
| Duration | Variable |
| Types | N/A |
| Causes | Adverse drug reaction, infection |
| Risks | Medication use, viral infections |
| Diagnosis | Clinical examination, biopsy |
| Differential diagnosis | Pemphigus vulgaris, toxic epidermal necrolysis |
| Prevention | N/A |
| Treatment | Corticosteroids, supportive care |
| Medication | Antibiotics, analgesics |
| Prognosis | Variable, can be severe |
| Frequency | Rare |
| Deaths | N/A |
Oculomucocutaneous syndrome is a rare medical condition that affects the eyes, mucous membranes, and skin. It is often associated with the use of certain medications, particularly the drug practolol, a beta-blocker used to treat high blood pressure and heart conditions.
Symptoms[edit]
The symptoms of oculomucocutaneous syndrome can vary widely, but often include:
- Dry eyes
- Conjunctivitis (inflammation of the eye)
- Blepharitis (inflammation of the eyelids)
- Skin rash
- Mucous membrane abnormalities
Causes[edit]
Oculomucocutaneous syndrome is most commonly associated with the use of the drug practolol. However, it can also occur as a result of other medications or underlying health conditions.
Diagnosis[edit]
Diagnosis of oculomucocutaneous syndrome is typically based on the presence of characteristic symptoms and a history of exposure to certain medications. Additional tests, such as a skin biopsy, may be performed to confirm the diagnosis.
Treatment[edit]
Treatment for oculomucocutaneous syndrome typically involves discontinuing the medication that is causing the condition. Additional treatments, such as topical steroids or artificial tears, may be used to manage symptoms.